UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?

Therapeutic advances in medical oncology, 2019-08, Vol.11, p.1758835919861905-1758835919861905

2019

Volltextzugriff (PDF)

Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?

International journal of molecular sciences, 2020-10, Vol.21 (21), p.7935

2020

Volltextzugriff (PDF)

Special Issue: "Gastrointestinal Cancers and Personalized Medicine"

Journal of personalized medicine, 2022-02, Vol.12 (3), p.338

2022

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3117-3125

2009

Volltextzugriff (PDF)

Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy

Endocrine, 2021-10, Vol.74 (1), p.172-179

2021

Volltextzugriff (PDF)

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

International journal of molecular sciences, 2020-01, Vol.21 (2), p.448

2020

Volltextzugriff (PDF)

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Journal of clinical oncology, 2010-02, Vol.28 (5), p.866-871

2010

Volltextzugriff (PDF)

Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer

Cancers, 2021-12, Vol.13 (24), p.6226

2021

Volltextzugriff (PDF)

Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study

Annals of nuclear medicine, 2023-01, Vol.37 (1), p.1-9

2023

Volltextzugriff (PDF)

Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management

Cancers, 2023-05, Vol.15 (10), p.2746

2023

Volltextzugriff (PDF)

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

PloS one, 2015-12, Vol.10 (12), p.e0144000-e0144000

2015

Volltextzugriff (PDF)

Characterization and Separation of Platinum-Based Antineoplastic Drugs by Zwitterionic Hydrophilic Interaction Liquid Chromatography (HILIC)–Tandem Mass Spectrometry, and Its Application in Surface Wipe Sampling

Separations, 2021-05, Vol.8 (5), p.69

2021

Volltextzugriff (PDF)

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer

Gastroenterology research and practice, 2018-01, Vol.2018, p.5353727-14

2018

Volltextzugriff (PDF)

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

International journal of cancer, 2011-04, Vol.128 (8), p.1935-1945

2011

Volltextzugriff (PDF)

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next

Cancer chemotherapy and pharmacology, 2022-09, Vol.90 (3), p.191-205

2022

Volltextzugriff (PDF)

RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

International journal of cancer, 2019-11, Vol.145 (9), p.2580-2593

2019

Volltextzugriff (PDF)

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

European journal of cancer (1990), 2021-02, Vol.144, p.101-112

2021

Volltextzugriff (PDF)

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

Annals of oncology, 2014-12, Vol.25 (12), p.2378-2385

2014

Volltextzugriff (PDF)

High-Resolution Melting Analysis for Rapid Detection of KRAS, BRAF, and PIK3CA Gene Mutations in Colorectal Cancer

American journal of clinical pathology, 2008-08, Vol.130 (2), p.247-253

2008

Volltextzugriff (PDF)

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

European journal of cancer (1990), 2017-09, Vol.82, p.16-24

2017

Volltextzugriff (PDF)

In vitro assessment of antibody-conjugated gold nanorods for systemic injections

Journal of nanobiotechnology, 2014-12, Vol.12 (1), p.55-55, Article 55

2014

Volltextzugriff (PDF)

Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors

Molecular and clinical oncology, 2018-12, Vol.9 (6), p.635-639

2018

Volltextzugriff (PDF)

Raltitrexed (Tomudex® ) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

European journal of cancer (1990), 2008-10, Vol.44 (15), p.2204-2211

2008

Volltextzugriff (PDF)

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

European journal of cancer (1990), 2005-09, Vol.41 (14), p.2176-2183

2005

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Results from a meta-analysis of immune checkpoint inhibitors in first-line renal cancer patients: does PD-L1 matter?

Focus on Biochemical and Clinical Predictors of Response to Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma: Where Do We Stand?

Special Issue: "Gastrointestinal Cancers and Personalized Medicine"

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Endocrine-related adverse events in a large series of cancer patients treated with anti-PD1 therapy

Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis

Genotype-Driven Phase I Study of Irinotecan Administered in Combination With Fluorouracil/Leucovorin in Patients With Metastatic Colorectal Cancer

Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer

Added prognostic value of molecular imaging parameters over proliferation index in typical lung carcinoid: an [18F]FDG PET/CT and SSTR imaging study

Principles of Molecular Utility for CMS Classification in Colorectal Cancer Management

HLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

Artificial Intelligence Predictive Models of Response to Cytotoxic Chemotherapy Alone or Combined to Targeted Therapy for Metastatic Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

Characterization and Separation of Platinum-Based Antineoplastic Drugs by Zwitterionic Hydrophilic Interaction Liquid Chromatography (HILIC)–Tandem Mass Spectrometry, and Its Application in Surface Wipe Sampling

Analysis of Prognostic Factors for Resected Synchronous and Metachronous Liver Metastases from Colorectal Cancer

Identification of potential pharmacogenomic markers of clinical efficacy of 5‐fluorouracil in colorectal cancer

An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next

RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Prognostic variables in low and high risk stage III colon cancers treated in two adjuvant chemotherapy trials

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset

High-Resolution Melting Analysis for Rapid Detection of KRAS, BRAF, and PIK3CA Gene Mutations in Colorectal Cancer

Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX

In vitro assessment of antibody-conjugated gold nanorods for systemic injections

Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors

Raltitrexed (Tomudex® ) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1)

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

Aktive Filter

Suchergebnisse filtern